Detalhe da pesquisa
1.
First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of SPR720, a Novel Oral Bacterial DNA Gyrase (GyrB) Inhibitor for Mycobacterial Infections.
Antimicrob Agents Chemother
; 65(11): e0120821, 2021 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34491803